These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38326066)

  • 21. Optical coherence tomographic analysis of drug-eluting in-stent restenosis at different times: A STROBE compliant study.
    Feng C; Zhang P; Han B; Li X; Liu Y; Niu D; Shi Y
    Medicine (Baltimore); 2018 Aug; 97(34):e12117. PubMed ID: 30142870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between non-culprit lesion plaque characteristics changes and in-stent neoatherosclerosis formation: 1-year follow-up optical coherence tomography study.
    Xing L; Zou Y; Fu C; Fan X; Wang X; Liu Q; Yang M; Liu D; Feng L; Hou J; Huang X
    Rev Cardiovasc Med; 2021 Dec; 22(4):1693-1700. PubMed ID: 34957812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis.
    Nakamura D; Dohi T; Ishihara T; Kikuchi A; Mori N; Yokoi K; Shiraki T; Mizote I; Mano T; Higuchi Y; Yamada T; Nishino M; Sakata Y
    EuroIntervention; 2021 Aug; 17(6):489-496. PubMed ID: 32985411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography.
    Huang WC; Teng HI; Chen HY; Wu CJ; Tsai CT; Hsueh CH; Chen YY; Hau WK; Lu TM
    Int J Cardiol; 2019 Aug; 289():131-137. PubMed ID: 31079970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein (a) is related to In-Stent neoatherosclerosis incidence rate and plaque vulnerability: Optical Coherence Tomography Study.
    Yuan X; Han Y; Hu X; Jiang M; Feng H; Fang Y; Liu M; Chen Y; Gao L
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):275-284. PubMed ID: 36315364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
    Araki T; Nakamura M; Sugi K
    J Cardiol; 2014 Dec; 64(6):423-9. PubMed ID: 24794755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, clinical presentation, and predictors of early neoatherosclerosis after drug-eluting stent implantation.
    Kim C; Kim BK; Lee SY; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Am Heart J; 2015 Sep; 170(3):591-7. PubMed ID: 26385044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of neointimal tissue characterization and heterogeneity of bare-metal stents and drug-eluting stents on the time course after stent implantation evaluated by integrated backscatter intravascular ultrasound.
    Yoshizane T; Tanaka S; Abe S; Ueno T; Goto Y; Kojima T; Iwama M; Arai M; Noda T; Kawasaki M
    Heart Vessels; 2019 Oct; 34(10):1639-1649. PubMed ID: 30997558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-target lesion progression: Unveiling critical predictors and outcomes in patients with in-stent restenosis.
    Zhang W; Zhang W; Deng Y; Gu N; Qiu Z; Deng C; Yang S; Pan L; Long S; Wang Y; Zhao Y; Shi B
    Int J Cardiol; 2024 Dec; 416():132451. PubMed ID: 39147280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of integrated backscatter intravascular ultrasound in characterizing bare metal and drug-eluting stent restenotic neointima as compared to optical coherence tomography.
    Sato K; Costopoulos C; Takebayashi H; Naganuma T; Miyazaki T; Goto K; Yamane H; Hagikura A; Kikuta Y; Taniguchi M; Hiramatsu S; Ito H; Colombo A; Haruta S
    J Cardiol; 2014 Dec; 64(6):488-95. PubMed ID: 24794757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal course of neointimal hyperplasia following drug-eluting stent implantation: a serial follow-up optical coherence tomography analysis.
    Lee SY; Hong MK; Mintz GS; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Int J Cardiovasc Imaging; 2014 Aug; 30(6):1003-11. PubMed ID: 24807243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
    Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
    Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.
    Nishino M; Lee Y; Nakamura D; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Invasive Cardiol; 2012 Oct; 24(10):478-83. PubMed ID: 23043029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and Predictors of Neoatherosclerosis in Patients with Early In-Stent Restenosis Determined Using Optical Coherence Tomography.
    Meng L; Liu X; Yu H; Wei G; Gu X; Chang X; Xie M; Qu W; Peng X; Sun Y; Tian J; Yu B
    Int Heart J; 2020 Sep; 61(5):872-878. PubMed ID: 32921669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.
    Ko YG; Kim DM; Cho JM; Choi SY; Yoon JH; Kim JS; Kim BK; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):715-23. PubMed ID: 21656060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical coherence tomography evaluation of in-stent restenotic lesions with visible microvessels.
    Kim BK; Kim JS; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
    J Invasive Cardiol; 2012 Mar; 24(3):116-20. PubMed ID: 22388303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography.
    Goto K; Takebayashi H; Kihara Y; Hagikura A; Fujiwara Y; Kikuta Y; Sato K; Kodama S; Taniguchi M; Hiramatsu S; Haruta S
    EuroIntervention; 2013 Sep; 9(5):601-7. PubMed ID: 23518860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.